chr13:32912414:G>T Detail (hg19) (BRCA2)

Go to:

Summary
Information
Links
Disease area statistics
MGeND
ClinVar
CIViC
DisGeNET
Annotation
Genome browser

Information

Genome

Assembly	Position
hg19	chr13:32,912,414-32,912,414
hg38	chr13:32,338,277-32,338,277 View the variant detail on this assembly version.

HGVS

BRCA2

Type	Transcript	Protein
RefSeq	NM_000059.3:c.3922G>T	NP_000050.2:p.Glu1308Ter
Ensemble	ENST00000713678.1:c.3922G>T	ENST00000713678.1:p.Glu1308Ter
	ENST00000713680.1:c.3922G>T	ENST00000713680.1:p.Glu1308Ter
	ENST00000700202.2:c.3922G>T	ENST00000700202.2:p.Glu1308Ter
	ENST00000530893.7:c.3553G>T	ENST00000530893.7:p.Glu1185Ter
	ENST00000380152.8:c.3922G>T	ENST00000380152.8:p.Glu1308Ter
	ENST00000544455.6:c.3922G>T	ENST00000544455.6:p.Glu1308Ter

Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics	Show details

Frequency

[No Data.]

Prediction

ClinVar

Clinical Significance	Pathogenic
Review star
Show details

Links

BRCA2

Type	Database	ID	Link
Gene	MIM	600185	OMIM
	HGNC	1101	HGNC
	Ensembl	ENSG00000139618	Ensembl
	NCBI		NCBI
	Gene Cards		Gene Cards
	OncoKB		OncoKB

Type	Database	ID	Link
Variant	TogoVar
	COSMIC
	MONDO

Disease area statistics

[No Data.]

MGeND

[No Data.]

ClinVar

Clinical significance	Last evaluated	Review status	Condition	Origin	Links
Pathogenic	2016-09-08	reviewed by expert panel	Breast-ovarian cancer, familial, susceptibility to, 2	unknown germline paternal	Detail
Pathogenic	2023-08-31	criteria provided, multiple submitters, no conflicts	not provided	germline unknown	Detail
Pathogenic	2023-12-27	criteria provided, multiple submitters, no conflicts	Hereditary cancer-predisposing syndrome	germline	Detail
Pathogenic	2024-01-31	criteria provided, multiple submitters, no conflicts	hereditary breast ovarian cancer syndrome	germline maternal	Detail
Pathogenic	2017-02-23	criteria provided, single submitter	Familial cancer of breast	germline	Detail
Pathogenic	2021-09-27	criteria provided, single submitter	Pancreatic cancer, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Fanconi anemia complementation group D1,Malignant tumor of prostate,medulloblastoma	unknown	Detail
Pathogenic	2021-09-27	criteria provided, single submitter	Pancreatic cancer, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Fanconi anemia complementation group D1,Malignant tumor of prostate,medulloblastoma	unknown	Detail
Pathogenic	2021-09-27	criteria provided, single submitter	Pancreatic cancer, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Fanconi anemia complementation group D1,Malignant tumor of prostate,medulloblastoma	unknown	Detail
Pathogenic	2021-09-27	criteria provided, single submitter	Pancreatic cancer, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Fanconi anemia complementation group D1,Malignant tumor of prostate,medulloblastoma	unknown	Detail
Pathogenic	2021-09-27	criteria provided, single submitter	Pancreatic cancer, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Fanconi anemia complementation group D1,Malignant tumor of prostate,medulloblastoma	unknown	Detail
Pathogenic	2021-09-27	criteria provided, single submitter	Pancreatic cancer, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Fanconi anemia complementation group D1,Malignant tumor of prostate,medulloblastoma	unknown	Detail
Pathogenic	2021-09-27	criteria provided, single submitter	Pancreatic cancer, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Fanconi anemia complementation group D1,Malignant tumor of prostate,medulloblastoma	unknown	Detail
Pathogenic	2021-09-27	criteria provided, single submitter	Pancreatic cancer, susceptibility to, 2,Familial cancer of breast,Glioma susceptibility 3,Breast-ovarian cancer, familial, susceptibility to, 2,Wilms tumor 1,Fanconi anemia complementation group D1,Malignant tumor of prostate,medulloblastoma	unknown	Detail
Pathogenic	2023-12-20	criteria provided, single submitter	BRCA2-related disorder	germline	Detail

CIViC

[No Data.]

DisGeNET

Score	Disease name	Description	Source	Pubmed	Links
0.240	Breast-ovarian cancer, familial, susceptibility to, 2	NA	CLINVAR		Detail
0.174	Breast Cancer, Familial	NA	CLINVAR		Detail
0.391	Hereditary Breast and Ovarian Cancer Syndrome	NA	CLINVAR		Detail
0.128	Neoplastic Syndromes, Hereditary	NA	CLINVAR		Detail
0.241	medulloblastoma	Two other kindreds each contained a Fanconi anemia-afflicted child who developed...	BeFree	14559878	Detail
0.267	Fanconi anemia	Two other kindreds each contained a Fanconi anemia-afflicted child who developed...	BeFree	14559878	Detail
0.016	FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	Two other kindreds each contained a Fanconi anemia-afflicted child who developed...	BeFree	14559878	Detail

Annotation

Annotations

Descrption	Source	Links
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND Breast-ovarian cancer, familial, susceptibility to, ...	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND not provided	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND Hereditary cancer-predisposing syndrome	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND Hereditary breast ovarian cancer syndrome	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND Familial cancer of breast	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND multiple conditions	ClinVar	Detail
NM_000059.4(BRCA2):c.3922G>T (p.Glu1308Ter) AND BRCA2-related disorder	ClinVar	Detail
NA	DisGeNET	Detail
NA	DisGeNET	Detail
NA	DisGeNET	Detail
NA	DisGeNET	Detail
Two other kindreds each contained a Fanconi anemia-afflicted child who developed medulloblastoma; on...	DisGeNET	Detail
Two other kindreds each contained a Fanconi anemia-afflicted child who developed medulloblastoma; on...	DisGeNET	Detail
Two other kindreds each contained a Fanconi anemia-afflicted child who developed medulloblastoma; on...	DisGeNET	Detail

Overlapped Transcript Coordinates

Gene	Transcript ID	Exon Number	Chromosome	Start	Stop	Type	Amino Mutation	Transcript Position	Links

Overlapped Transcript

Gene	Transcript ID	Chromosome	Start	Stop	Links

Gene: -
dbSNP: rs80358638 dbSNP
Genome: hg19
Position: chr13:32,912,414-32,912,414
Variant Type: snv
Reference Allele: G
Alternative Allele: T

Genome browser